Preclinical evidence has shown 5-HT1A receptor knockout mice demonstrate increased anxiety and fear response (Ramboz et al., 1998), suggesting that 5-HT1A agonist may have therapeutic implications in PTSD. This evidence concerns the gene HTR1A and post-traumatic stress disorder.